QIA invests in innovative healthcare firm Kardium
Doha
Qatar Investment Authority (QIA) has invested in innovative healthcare company, Kardium, the developer of the Globe Pulsed Field System– an innovative treatment for atrial fibrillation (AF).
In a press release on Wednesday, QIA said that Kardium has raised $250 million in a new financing round. QIA was joined by other new investors Janus Henderson Investors, MM Capital, Piper Heartland Healthcare Capital, Eventide Asset Management, and Eckuity Capital in leading the round.
Existing investors also participated, including funds and accounts advised by T Rowe Price Associates, T Rowe Price Investment Management and Durable Capital Partners LP. The financing also includes an equity investment from a leading strategic investor.
'We're thrilled to have secured this transformational financing with a world-class syndicate of investors,' said Kevin Chaplin, CEO ofKardium.
'This funding enables us to move ahead with the commercial launch of the Globe System by expanding our manufacturing capabilities and building a strong commercial team.
Everyone at Kardium is energised by the opportunity to bring the Globe System to market and help improve the lives of millions of patients worldwide suffering from atrial fibrillation.'
Impressive clinical data from the pivotal PULSAR clinical study of the Globe System demonstrates remarkable results with the Globe System, showing freedom from atrial arrhythmia at 1 year of 78 percent in paroxysmal AF patients, with 0 percent device-relatedprimary safety events.
The new funding will enable Kardium to pursue regulatory approvals for the Globe System, further expand its manufacturing facilities and production capacity, and establish a clinical support and commercial team in preparation for the anticipated commercial launch of the Globe System later this year.
The Globe Pulsed Field System consists of a sophisticated catheter with a 122-electrode array and advanced software that enables rapid pulmonary vein isolation, high-definition mapping, and the ability to ablate anywhere in the atrium – all with a single catheter.
Kardium is a rapidly growing, privately held medical solutions company that has developed an advanced system for atrial fibrillation (AF) treatment: the Globe System.
Kardium has built an outstanding team, who have worked with top medical advisors to develop the GlobeSystem.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Qatar Tribune
02-07-2025
- Qatar Tribune
QIA invests in Kardium
Qatar Investment Authority (QIA) has invested in innovative healthcare company, Kardium Inc., the developer of the Globe's Pulsed Field System,an innovative treatment for atrial fibrillation (AF). In a press release on Wednesday, QIA said that Kardium Inc. has raised $250 million in a new financing round. QIA was joined by other new investors Janus Henderson Investors, MM Capital, Piper Heartland Healthcare Capital, Eventide Asset Management, and Eckuity Capital in leading the round. (QNA) page 11
Qatar Tribune
02-07-2025
- Qatar Tribune
QIA invests in innovative healthcare firm Kardium
QNA Doha Qatar Investment Authority (QIA) has invested in innovative healthcare company, Kardium, the developer of the Globe Pulsed Field System– an innovative treatment for atrial fibrillation (AF). In a press release on Wednesday, QIA said that Kardium has raised $250 million in a new financing round. QIA was joined by other new investors Janus Henderson Investors, MM Capital, Piper Heartland Healthcare Capital, Eventide Asset Management, and Eckuity Capital in leading the round. Existing investors also participated, including funds and accounts advised by T Rowe Price Associates, T Rowe Price Investment Management and Durable Capital Partners LP. The financing also includes an equity investment from a leading strategic investor. 'We're thrilled to have secured this transformational financing with a world-class syndicate of investors,' said Kevin Chaplin, CEO ofKardium. 'This funding enables us to move ahead with the commercial launch of the Globe System by expanding our manufacturing capabilities and building a strong commercial team. Everyone at Kardium is energised by the opportunity to bring the Globe System to market and help improve the lives of millions of patients worldwide suffering from atrial fibrillation.' Impressive clinical data from the pivotal PULSAR clinical study of the Globe System demonstrates remarkable results with the Globe System, showing freedom from atrial arrhythmia at 1 year of 78 percent in paroxysmal AF patients, with 0 percent device-relatedprimary safety events. The new funding will enable Kardium to pursue regulatory approvals for the Globe System, further expand its manufacturing facilities and production capacity, and establish a clinical support and commercial team in preparation for the anticipated commercial launch of the Globe System later this year. The Globe Pulsed Field System consists of a sophisticated catheter with a 122-electrode array and advanced software that enables rapid pulmonary vein isolation, high-definition mapping, and the ability to ablate anywhere in the atrium – all with a single catheter. Kardium is a rapidly growing, privately held medical solutions company that has developed an advanced system for atrial fibrillation (AF) treatment: the Globe System. Kardium has built an outstanding team, who have worked with top medical advisors to develop the GlobeSystem.
Qatar Tribune
29-06-2025
- Qatar Tribune
QSE welcomes $200 mn Fiera Fund
QNA Doha The Qatar Stock Exchange (QSE) has welcomed the announcement by the Qatar Investment Authority (QIA) of a strategic partnership with Fiera Capital to launch the $200 million Fiera Qatar Equity Fund, a landmark initiative aimed at enhancing market liquidity, increasing the free float of Qatari equities, and attracting new institutional capital to the Qatari market. This initiative reflects QIA's continued commitment to advancing Qatar's economic diversification and strengthening key sectors, notably financial markets and asset management, according to a statement issued on the QSE website. The engagement of active fund managers represents a significant step in broadening the investor base and boosting free float shares in the market. As the anchor investor, QIA will convert a portion of its long-term strategic holdings in listed Qatari companies into assets managed actively within the fund. This approach is expected to inject substantial new liquidity into the market, facilitate greater institutional participation, and attract a wider range of global investors to Qatar's evolving financial landscape. QSE considers this fund a strategic addition to the suite of specialised investment products in the local market. It will play a critical role in diversifying the investor base, supporting sustainable, high-quality capital inflows, and reinforcing Qatar's position as a leading regional financial hub. The exchange also reaffirmed its commitment to continued collaboration with QIA on initiatives that contribute to the objectives of the Third Financial Sector Strategy and Qatar National Vision 2030. QIA has been instrumental in strengthening Qatar's capital markets through a series of targeted programs, including the Market Making initiative, the Securities Lending and Borrowing framework, and the Active Asset Management initiative launched in 2024. These efforts have already delivered tangible results, including the $200 million Qatar-focused equity fund launched in partnership with Ashmore Group. The newly announced collaboration with Fiera Capital marks another important milestone in expanding market participation and supporting the long-term growth of Qatar's financial ecosystem.
